Contraceptive and sexually transmitted diseases protection among adult and adolescent women infected with human immunodeficiency virus

International Journal of STD and AIDS

Volumn 7, Issue 6, 1996, Pages 439-442

  Clark, Rebecca A ^a,b   Kissinger, Patricia ^a   Williams, Troylynn ^a  

^a Memorial Medical Center New Orleans   (United States)

^b LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

Author keywords

Contraception; Sexually transmitted diseases

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ADOLESCENT; ADULT; ARTICLE; CONDOM; CONTRACEPTION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SEXUALLY TRANSMITTED DISEASE;

ACQUIRED IMMUNODEFICIENCY SYNDROME--PREVENTION AND CONTROL; ADOLESCENTS; ADOLESCENTS, FEMALE; AGE FACTORS; AMERICAS; BLACKS--WOMEN; CONTRACEPTION; CONTRACEPTIVE AGENTS, FEMALE--SIDE EFFECTS; CONTRACEPTIVE AGENTS, PROGESTIN--SIDE EFFECTS; CONTRACEPTIVE AGENTS--SIDE EFFECTS; CONTRACEPTIVE USAGE; CULTURAL BACKGROUND; DEMOGRAPHIC FACTORS; DEVELOPED COUNTRIES; DISEASES; ETHNIC GROUPS; FAMILY PLANNING; HIV INFECTIONS--PREVENTION AND CONTROL; INFECTIONS; NORTH AMERICA; NORTHERN AMERICA; POPULATION; POPULATION CHARACTERISTICS; REPRODUCTIVE TRACT INFECTIONS; RESEARCH METHODOLOGY; RESEARCH REPORT; RETROSPECTIVE STUDIES; SEXUALLY TRANSMITTED DISEASES--PREVENTION AND CONTROL; STUDIES; UNITED STATES; VIRAL DISEASES; YOUTH;

ADOLESCENT; ADULT; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; CONDOMS; CONTRACEPTION; CONTRACEPTIVES, ORAL, HORMONAL; FEMALE; HIV INFECTIONS; HUMANS; MULTIVARIATE ANALYSIS; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; SEXUALLY TRANSMITTED DISEASES;

EID: 0029824244     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/0956462961918275     Document Type: Article

References (16)

1. Rosenberg MJ, Gollub EL. Commentary: methods women can use that may prevent sexually transmitted disease, including HIV. Am J Pub Health 1992;82:1473-8
2. Spence MR, Reboli AC. Human immunodeficiency virus infection in women (editorial). Ann Intern Med 1991;115:827-9
3. Carpenter CC, Mayer KH, Stein MD, Leibman BD, Fisher A, Fiore TC. Human immunodeficiency virus infection in North American women: experience with 200 cases and a review of the literature. Medicine (Baltimore) 1991;70:307-25
4. Jensen HK, Hansen PA, Blom J. Incidence of Candida albicans in women using oral contraceptives. Acta Obstet Gynec Scand 1970;49:293-6
5. Hildesheim A, Reeves WC, Brinton LA, et al. Association of oral contraceptive use and human papilloma viruses in invasive cervical cancers, Int J Cancer 1990;45:860-4
6. Beral V, Hannaford P, Kay C. Oral contraceptive use and malignancies of the genital tract: results from the Royal College of General Practitioners' Oral Contraception Study. Lancet 1988;2:1331-5
7. Washington AE, Gove S, Schachter J, Sweet RL. Oral contraceptives, Chlamydia trachomatis infection, and pelvic inflammatory disease. JAMA 1985;253:2246-50
8. Goldacre MJ, Loudon N, Watt B, et al. Epidemiology and clinical significance of cervical erosion in women attending a family planning clinic. BMJ 1978;1:748-50
9. Centers for Disease Control. Surgical sterilization among women and use of condoms - Baltimore. MM WR 1992;41:568-74
10. Centers for Disease Control. HIV-risk behaviors of sterilized and nonsterilized women in drug-treatment programs - Philadelphia, 1989-1991. MMWR 1992;41:149-51
11. Rubin GL, Ory HW, Layde PM. Oral contraceptives and pelvic inflammatory disease. Am J Obstet Gynecol 1982;144:630-5
12. Moghissi KS, FACOG, Syner FN, McBride LC. Contraceptive mechanism of microdose norethindrone. Obstet Gynecol 1973;41:585-94
13. Duerr A, Sierra M, Clarke L, Landesman S, Ehrlich I, Minkoff H. Vaginal candidiasis among HIV-infected women (abstract no PO-B01-08800). In: Program and Oral Abstracts of the 9th International Conference on AIDS, Berlin. World Health Organization, International AIDS Society, 1993: 282
14. Koutsky LA, Holmes KK, Critchlow CW, et al. A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med 1992;327:1272-8
15. Baird DT, Glasier AF. Hormonal contraception. N Engl J Med 1993;328:1543-9
16. Zenilman JM, Weisman CS, Rompalo AM, Ellish N, Upchurch DM, Hook EW, Celentano D. Condom use to prevent incident STDs: the validity of self-reported condom use. Sex Trans Dis 1995;22:15-21